Steven got his PhD in Microbiology and Molecular Genetics at the University of Medicine and Dentistry of New Jersey (now part of Rutgers University). After a short post-doc on antimicrobial coatings, Steven joined Roche Diagnostics in 2011. He has worked in Customer Support, Quality and Regulatory, and Medical Affairs in the Molecular Diagnostics space, focusing on Infectious Diseases. He then joined Genentech in 2021 and has supported Medical Affairs for baloxavir (Xofluza) as well as other molecules in the Respiratory Therapeutic Area.